企業プロフィール · Financial Services

Aflac Incorporated

AFL · 米国株
業種
Insurance
取引所
米国株
国 / 地域
USA
上場日
1984年7月19日
従業員数
12,716
公式サイト
www.aflac.com
現在値
$126.56
リアルタイム · 2026年7月27日
ベイリー成長スコア
44/100
やや弱い
本源的価値 · 3 段階レンジ 現在値 $126.56 リアルタイム · 妥当レンジと楽観的レンジの間

総合バリュエーションレンジ · 保守的 $80–$95 / 妥当 $100–$120 / 楽観的 $130–$150。$126.56 時点で 妥当レンジと楽観的レンジの間。

レポート公開時 $117.86(2026年5月23日)

時価総額$629億
売上高(TTM)$181.12億
EBITDA$58.8億
純利益率25.6%
ROE16.47%
PER (TTM)14.35
予想PER14.53
PEG1.18
EPS$8.75
配当利回り1.89%
52週レンジ$94.93 – $125.93
アナリスト目標株価$117.71
アナリスト評価2.9 / 5

データ提供:EODHD、報告通貨で表示。参考情報であり、投資助言ではありません。

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates in two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care, whole life, and GIFT insurance products, as well as WAYS and child endowment, and Tsumitasu insurance products in Japan. Its Aflac U.S. segment provides accident, disability, cancer, critical illness, hospital indemnity, dental, vision, and life insurance products in the United States. The company also provides hearing, final expense, pet, Medicare supplement, supplemental dental and vision, short-term disability, and absence management insurance products, as well as cafeteria plans. It sells its products to individuals, families, and business owners through individual, independent corporate, and affiliated corporate agencies; banks; independent associates/career agents; and brokers. Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia.

沿革

Aflac Incorporated was founded in 1955 and is headquartered in Columbus, Georgia. Its Aflac Japan operation pioneered Japan's cancer insurance market in 1974. The company completed its IPO on July 19, 1984. Following the deregulation of Japan's market in 2001, more independent cancer and medical insurance providers entered the field. Daniel P. Amos has served as CEO since 1990 and as chairman since 2001.

業界での地位

Aflac is a supplemental health and life insurer operating through two segments, Aflac Japan and Aflac U.S. Aflac Japan is the leading provider of cancer and medical insurance by policies in force in Japan and contributed about 53% of adjusted revenue and roughly 69% of pretax adjusted profit in 2025. Its Japan distribution spans about 6,300 sales agencies, roughly 112,000 licensed sales personnel, a Dai-ichi Life partnership covering about 37,000 representatives, Japan Post coverage of about 20,000 post offices, and agreements with about 90% of Japan's banks; the U.S. relies on about 5,300 producing agents and brokers. As of May 22, 2026 its market capitalization was about $60.67 billion, with 12,716 employees. Comparable insurers include Globe Life, MetLife, Prudential, and Unum.

この銘柄のレポートはお使いの言語でまだありません。